30

Shanxi Zhendong Pharmaceutical Co LtdSHE 300158 Stock Report

Last reporting period 30 Sep, 2023

Updated 14 Nov, 2024

Last price

Market cap $B

0.332

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300158.SZ Stock Analysis

30

Uncovered

Shanxi Zhendong Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

9/100

Low score

Market cap $B

0.332

Dividend yield

25.35 %

Shares outstanding

1 030.93 B

Shanxi Zhendong Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and distribution of Chinese traditional medicines and western medicines. The company is headquartered in Changzhi, Shanxi and currently employs 4,123 full-time employees. The company went IPO on 2011-01-07. The firm's main products include anti-tumor series, cardiovascular and cerebrovascular series, anti-infection series, digestive system series, vitamin nutrition series, respiratory system series, antipyretic analgesic series and nervous system series. The firm is also involved in the cultivation of medicinal herbs, as well as the wholesale and retail of pharmaceutical products. The firm distributes its products in domestic market, with North China market as its main market.

View Section: Eyestock Rating